summary
Introduced
04/06/2023
04/06/2023
In Committee
04/14/2023
04/14/2023
Crossed Over
Passed
Dead
01/03/2025
01/03/2025
Introduced Session
118th Congress
Bill Summary
A BILL To amend the Federal Food, Drug, and Cosmetic Act to expand certain authorities with respect to the recall of controlled substances to apply with respect to all drugs, and for other purposes.
AI Summary
This bill amends the Federal Food, Drug, and Cosmetic Act to expand the Food and Drug Administration's (FDA) authority to order the recall of any unsafe drug, not just controlled substances. Specifically, it allows the FDA to order a drug manufacturer to cease distribution and recall a drug if there is a reasonable probability that the drug is unsafe for humans or animals. This expanded authority applies to all drugs, not just controlled substances, as was previously the case. The bill also clarifies that the FDA can issue such orders not just through the Director of the Center for Drug Evaluation and Research, but also through the Director of the Center for Biologics Evaluation and Research.
Committee Categories
Business and Industry, Health and Social Services
Sponsors (2)
Last Action
Referred to the Subcommittee on Health. (on 04/14/2023)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.congress.gov/bill/118th-congress/house-bill/2500/all-info |
| BillText | https://www.congress.gov/118/bills/hr2500/BILLS-118hr2500ih.pdf |
Loading...